For the quarter ended March 2024, Zimmer Biomet (ZBH) reported revenue of $1.89 billion, up 3.2$1.94, compared to $1.89 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of$1.87 billion, representing a surprise of +1.16%. The company delivered an EPS surprise of +3.74%, with the consensus EPS estimate being $1.87. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...